Lu, Jie <br/><br/>
Inhibition of serine/threonine phosphatase PP2A enhances cancer chemotherapy by blocking DNA damage induced defense mechanisms.  [electronic resource] 

 -  Proceedings of the National Academy of Sciences of the United States of America  Jul 2009 
 - 11697-702 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1091-6490 
<br/><br/><label>Standard No.: </label>10.1073/pnas.0905930106  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents, Alkylating--therapeutic use<br/>Blotting, Western<br/>Cell Cycle Proteins--metabolism<br/>DNA Damage<br/>Dacarbazine--analogs & derivatives<br/>Enzyme Inhibitors--pharmacology<br/>Flow Cytometry<br/>Fluorescent Antibody Technique<br/>Gene Expression Regulation, Enzymologic--drug effects<br/>Glioblastoma--drug therapy<br/>Mice<br/>Mice, SCID<br/>Neuroblastoma--drug therapy<br/>Protein Phosphatase 2--antagonists & inhibitors<br/>Protein Serine-Threonine Kinases--metabolism<br/>Proto-Oncogene Proteins--metabolism<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>Temozolomide<br/>Polo-Like Kinase 1